comparemela.com

Latest Breaking News On - C diff infection - Page 6 : comparemela.com

What s the Future of Microbiome Therapies in CDI, Cancer?

Preventive treatments for C difficile recurrence are in phase 3 trials. Oncologists are also investigating microbiome-based differences in treatment response.

United statesSahil khannaColleenr kellyJennifera wargoEuropean society for neurogastroenterologyUniversity of texas md anderson cancer centerDrug administrationFerring pharmaceuticalsHealth world summitBrown universityAmerican gastroenterological associationMayo clinicGut microbiotaHealth worldCancer centerEuropean society

Aerosolized Hydrogen Peroxide Can Significantly Reduce C difficile Infections

Aerosolized hydrogen peroxide is a new tool in fighting C. difficile in healthcare settings.

United statesChristopherl truittInfection controls incWayland baptist universityAmerican journalWayland baptistMedscape medical newsMedical newsInfection controlsSeres therapeuticsVedanta biosciencesC diff infectionClostridium difficile infectionLostridium difficile associated diseaseC diff associated diseaseInfection control

C difficile Vaccine: CLOVER Trial Shows Mixed Results

There s mixed news from Pfizer on results from the CLOVER trial of their candidate vaccine for preventing C diff infection.

David aronoffCenters for diseaseDepartment of medicine at indiana universityVaccine efficacyMedscape medical newsDisease controlMedical newsIndiana universityC diff infectionClostridium difficile infectionLostridium difficile associated diseaseC diff associated diseaseTherapeutic vaccineClinical researchClinical trialsLinical studies

Superdonor Samples Don t Increase FMT Success in UC

RESTORE-UC trial results contradict positive results seen in previous trials despite using highly standardized "superdonor" samples.

Region flamandeWalter reinischClara caenepeelMichaela kammUniversity of melbourneKamm gut research groupColitis organisationUniversity of viennaEuropean crohnFaecal microbiota transplantationUlcerative colitisMedical universityBiologic therapyC diff infectionClostridium difficile infectionLostridium difficile associated disease

C Difficile: New Vancomycin-Resistant Strains Raise Concerns

The detection of a marked increase in unrecognized strains of C difficile suggests a pressing need to understand mechanisms.

Nairobi areaUnited statesUniversity of texasCorneliusj clancyCharles darkohSociety for healthcare epidemiology of americaUniversity of pittsburghUniversity of texas health science centerInfectious diseases society of americaClinical infectiousInfectious diseasesHealthcare systemMedscape medicalInfectious diseases societyHealthcare epidemiologyTexas health science center

vimarsana © 2020. All Rights Reserved.